[Diabetes mellitus and cognitive decline]. (Q53427297)

14 May 2018

review article

1 reference

title

[Diabetes mellitus and cognitive decline]. (English)

1 reference

14 May 2018

author

Bernhard Iglseder

series ordinal

1

1 reference

14 May 2018

language of work or name

German

0 references

publication date

29 July 2011

1 reference

14 May 2018

Wiener Medizinische Wochenschrift

published in

1 reference

14 May 2018

volume

161

1 reference

14 May 2018

issue

21-22

1 reference

14 May 2018

page(s)

524-530

1 reference

14 May 2018

Number of dementia sufferers in Europe between the years 2000 and 2050.

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10354-011-0003-X

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-011-0003-X

Increased risk of Alzheimer's disease in Type II diabetes: insulin resistance of the brain or insulin-induced amyloid pathology?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-011-0003-X

Cognitive decline and dementia in diabetes--systematic overview of prospective observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-011-0003-X

A 4 year follow-up study of cognitive functioning in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-011-0003-X

Association of diabetes mellitus and dementia: the Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-011-0003-X

Diabetes and the risk of multi-system aging phenotypes: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-011-0003-X

Risk of dementia in diabetes mellitus: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-011-0003-X

Association of duration and severity of diabetes mellitus with mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-011-0003-X

Diabetes and other vascular risk factors for dementia: which factor matters most? A systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-011-0003-X

The relationship between type 2 diabetes and cognitive dysfunction: longitudinal studies and their methodological limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-011-0003-X

The effect of borderline diabetes on the risk of dementia and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-011-0003-X

Diabetes mellitus and risk of dementia in the Kungsholmen project: a 6-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-011-0003-X

Diabetes is associated with a slower rate of cognitive decline in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-011-0003-X

Promising strategies for the prevention of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-011-0003-X

Physical activity over the life course and its association with cognitive performance and impairment in old age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-011-0003-X

Insulin resistance syndrome and Alzheimer's disease: age- and obesity-related effects on memory, amyloid, and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-011-0003-X

Pathophysiology of cognitive dysfunction in older people with type 2 diabetes: vascular changes or neurodegeneration?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-011-0003-X

Hyperinsulinemia provokes synchronous increases in central inflammation and beta-amyloid in normal adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-011-0003-X

Insulin, insulin-degrading enzyme and amyloid-beta peptide in Alzheimer's disease: review and hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-011-0003-X

Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-011-0003-X

Defective insulin signaling pathway and increased glycogen synthase kinase-3 activity in the brain of diabetic mice: parallels with Alzheimer's disease and correction by insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-011-0003-X

Alzheimer's disease is type 3 diabetes-evidence reviewed

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-011-0003-X

The role of insulin resistance in the pathogenesis of Alzheimer's disease: implications for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-011-0003-X

White matter hyperintensities and cognitive dysfunction in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-011-0003-X

Diabetes, Alzheimer disease, and vascular dementia: a population-based neuropathologic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-011-0003-X

Effects of type 1 diabetes on gray matter density as measured by voxel-based morphometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-011-0003-X

Hippocampal volume and cognitive performance in long-standing Type 1 diabetic patients without macrovascular complications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-011-0003-X

Hippocampal volumes in youth with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-011-0003-X

The final frontier: how does diabetes affect the brain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-011-0003-X

Immunohistochemical analysis of human brain suggests pathological synergism of Alzheimer's disease and diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-011-0003-X

Cerebral glucose metabolism in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-011-0003-X

Central nervous system function in youth with type 1 diabetes 12 years after disease onset

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-011-0003-X

Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-011-0003-X

Activity-dependent regulation of neuronal plasticity and self repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-011-0003-X

Running increases cell proliferation and neurogenesis in the adult mouse dentate gyrus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-011-0003-X

Impairment of synaptic plasticity and memory formation in GLP-1 receptor KO mice: Interaction between type 2 diabetes and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-011-0003-X

PPARgamma agonists as therapeutics for the treatment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-011-0003-X

Antidiabetic drug metformin (GlucophageR) increases biogenesis of Alzheimer's amyloid peptides via up-regulating BACE1 transcription.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-011-0003-X

[Diabetes and cardiovascular complications]

21 January 2018

1 reference

12 December 2020

Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group.

1 reference

12 December 2020

Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study

1 reference

12 December 2020

Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory-impaired older adults.

1 reference

12 December 2020

AGEs/RAGE complex upregulates BACE1 via NF-κB pathway activation

1 reference

12 December 2020

Abnormalities of the glucose transporter at the blood-brain barrier and in brain in Alzheimer's disease.

1 reference

12 December 2020

Incidence of dementia is increased in type 2 diabetes and reduced by the use of sulfonylureas and metformin

1 reference

12 December 2020

Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer's disease.

1 reference

12 December 2020

Insulin signaling, diabetes mellitus and risk of Alzheimer disease.

1 reference

12 December 2020

Insulin resistance and hippocampal volume in women at risk for Alzheimer's disease

1 reference

12 December 2020

Targets for the prevention of dementia

1 reference

12 December 2020

10.1007/S10354-011-0003-X

Identifiers

DOI

1 reference

14 May 2018

release_2byfbnirmjh2lpshxi7kkjevl4

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2byfbnirmjh2lpshxi7kkjevl4

24 November 2022

mapped directly with Wikidata item

1 reference

14 May 2018